Turning Point Brands (TPB) has gained 106.3% since being added to Hedgeye’s Signal Strength Stocks on June 14, 2024.

We identified this “double bagger” through our proven “triple-tested” stock-picking process—combining fundamental, quantitative, and macro analysis.

TPB Has Doubled Since June—Why It's Still a Great Opportunity - cigareete

Consumables Analyst Howard Penney and our CEO Keith McCullough both believe this stock is headed higher.

Here’s how our investing process works:

1. Fundamentally Approved

TPB is a leader in the tobacco and nicotine alternative market, leveraging an asset-light model focused on branding and distribution across 217,000 North American locations.

Its modern oral nicotine product, FRĒ, is rapidly scaling and poised to capitalize on the growing $10–15 billion non-combustible nicotine market.

The company is expanding FRĒ into convenience stores and alternative channels like cannabis dispensaries while managing regulatory risks and supply chain complexities.

TPB's ability to navigate headwinds while executing on its strategic initiatives solidifies its position as a Best Idea Long for Hedgeye.

2. Signal Approved

On top of our research team's fundamental analysis, our quantitative signaling process plays the most important role.

Since Hedgeye CEO Keith McCullough’s signal turned bullish, and it was added to our Signal Strength Stocks product on 6/14/24, TPB has gone up 106.3%. Our signals incorporate fractal-based calculations to get ahead of big stock moves.

The best part? It’s not too late to get in on this winning stock pick, as our signal remains bullish, predicting a continued bullish trend for this stock.

However, this relies on a strong overall economy to promote growth. That’s where our extensive Macroeconomic analysis plays a role.

3. Macro: Neutral

TPB’s strategy fits well with Hedgeye’s Macro process, which looks for long-term growth opportunities in strong consumer markets.

The company is capitalizing on growing demand for oral nicotine products and expanding into cannabis and hemp, positioning itself to thrive alongside shifting consumer trends and regulatory changes.

As you can see, our triple-tested stock picking process that combines fundamental, quantitative, and macro analysis can be leveraged to help protect and grow your investments.

Don't miss out on our next top stock pick.

  • Subscribe to The Call @ Hedgeye and get our analysts' fundamental stock picks as soon as they become best ideas.

You're Leaving Hedgeye Risk Management...

By selecting this link, you are now leaving the Hedgeye Risk Management (“HRM”) website. The following website contains information concerning investment products managed by Hedgeye Asset Management (“HAM”), an affiliate of HRM, or a firm partnering with HAM, and is subject to HAM’s Privacy Policy. As a separate legal entity, all HAM asset management services are made independently by portfolio managers at HAM and, as such, funds may vary from HRM research.

HRM is not responsible for the accuracy or completeness of information on external websites. HRM does not make any representation regarding the advisability of investing in any investment product or any particular investment advisory. Any opinions or recommendations from linked websites are solely those of our affiliate and are not the opinions or recommendations of HRM.

HRM DOES NOT PROVIDE PERSONALIZED INVESTMENT ADVICE OR ENGAGE IN ANY ASSET MANAGEMENT SERVICE. LASTLY, THIS LINK IS NOT AN OFFER TO BUY OR A SOLICITATION TO SELL ANY SECURITY OR INVESTMENT PRODUCT, OR THE SOLICITATION OF ANY ADVISORY SERVICES.